Reverse merger

A reverse merger is a transaction in which a private company merges with an existing public company so that the private company's owners end up controlling the combined, publicly traded entity. It gives the private company a listing without running a traditional IPO.

How it works

The public company issues a large block of new shares to the private company's owners in exchange for their business. After closing, the private company's holders typically own most of the combined company, often 75% to 90% or more, and its management takes over. The combined company frequently changes its name and ticker and often does a reverse stock split.

The public partner is often a shell with little operating business, or a struggling company, especially a small-cap biotech whose lead drug failed but that still has cash and a listing. Biotech reverse mergers are commonly paired with a concurrent PIPE to fund the combined company. Exchanges treat a reverse merger with a change of control as a new listing that must meet initial listing standards, and the combined company files an 8-K with full information about the new business (often called a "super 8-K").

Why it matters for traders

Announcements can trigger huge, short-lived spikes in microcap shells, especially when the float is tiny. Existing holders of the public company are usually heavily diluted: their share of the combined business is small. Watch the ownership split, the size and price of any concurrent financing, whether legacy holders receive a CVR (a contingent value right tied to old assets), and lock-up terms for new insiders.

Example

Hypothetical Northwind Therapeutics (NWTX) has $30 million in cash after a failed Phase 2 trial and a $25 million market cap. It agrees to a reverse merger with private Contoso Bio, whose holders will own 85% of the combined company, alongside a $100 million PIPE. Legacy NWTX holders end up owning about 15% before the PIPE shares, and less after.

FAQ

Is a reverse merger the same as a SPAC deal?

They are similar in effect. A SPAC is a shell formed specifically to raise cash in an IPO and later merge; a reverse merger usually uses an existing operating or failed company.

Are reverse mergers good for existing shareholders?

They are usually highly dilutive for the public company's legacy holders, who end up owning a small minority of the combined company.